Ertugliflozin

Status:
Grey
Decision Date:
April 2019
 

Comments

GREY: 

  • Type 2 Diabetes without CKD: See local type 2 diabetes guidance. (Decision date -Dec 2022)
  • NICE TA572 : ertugliflozin as monotherapy or with metformin for treating type 2 diabetes. (Decision date - April 2019)
  • NICE TA583:  ertugliflozin with metformin and a DPP4 inhibitor for treating type 2 diabetes. (Decision date - July 2019)

 

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app